Effects of the antipsychotic drug sulpiride on reproductive hormones in healthy men: relationship with body weight regulation

• Published in: Pharmacopsychiatry Vol. 30; no. 6; p. 250
• Main Authors: Baptista, T, Alastre, T, Contreras, Q, Martinez, J L, Araujo de Baptista, E, Páez, X, Hernández, L
• Format: Journal Article
• Language: English
• Published: Germany 01.11.1997
• Subjects: Adult; Antipsychotic Agents - adverse effects; Body Weight - drug effects; Endocrine System Diseases - chemically induced; Gonadal Steroid Hormones - blood; Gonadotropins, Pituitary - blood; Humans; Lipids - blood; Male; Nutritional Status; Prolactin - blood; Sulpiride - adverse effects; Thyroid Hormones - blood
• DOI: 10.1055/s-2007-979502
• ISSN: 0176-3679

Metabolic and endocrine abnormalities secondary to hyperprolactinemia, particularly hypogonadism, may be involved in the excessive body weight gain observed during treatment with antipsychotic drugs. The present study was conducted in healthy men in order to detect an endocrine imbalance secondary to antipsychotic drug administration, which, if sustained in the long term, might be involved in the development of obesity. Sulpiride (200 mg daily for 30 days) or placebo was nonblindly administered, and body weight gain was correlated with the serum levels of prolactin, luteinizing hormone, follicle-stimulating hormone, estradiol, free testosterone, thyrotropic hormone, free tetraiodothyroxine, cortisol, dehydroepiandrosterone sulphate (DHEA-S), and the ratios estradiol/testosterone and testosterone/DHEA-S; the blood lipids were also assessed. Body weight gain and the serum levels of prolactin were significantly increased by sulpiride; in addition, a significant positive correlation was observed between prolactin levels and body weight gain. Other endocrine parameters were not significantly affected by the drug. These short-term results show that in healthy men, body weight can be increased by antipsychotic drug administration; this effect may be related to hyperprolactinemia alone, since other endocrine parameters were normal at the time of treatment. A more prolonged treatment with antipsychotic agents might be required to observe the alterations in gonadal and adrenal steroids often detected in subjects with primary obesity.